Should You Buy Archer Aviation Below $6?

Archer Aviation shares are down 61% from their 52-week high and trade below $6 as investors await commercialization of its Midnight eVTOL aircraft. The company is in Phase 4 of the FAA type-certification process, targets Abu Dhabi operations in late 2026, and expects U.S. passenger flights within the next several years. Its all-stock acquisition of Boeing's Wisk Aero, SkyGrid, and Insitu expands autonomous-flight, air-traffic-management, and defense capabilities, but Archer remains pre-commercial, capital intensive, and exposed to substantial execution risk.

Analysis

ACHR’s valuation discount is not principally a demand problem; it reflects an unusually long duration to cash generation combined with certification, manufacturing, and infrastructure dependencies. The defense/autonomy asset package could reduce the single-product valuation discount only if it brings contracted revenue, cleared backlog, and transferable engineering capacity rather than incremental R&D burn. Until transaction terms disclose the shares issued, assumed liabilities, and any Boeing commercial restrictions, the deal should be treated as potentially dilutive rather than automatically strategic.

Near term, certification/test milestones can drive sharp retail-led rallies, but these are unlikely to durably rerate ACHR without a quantified production ramp, unit economics, and funding runway. Over the next 1-3 months, the key catalyst is transaction documentation and evidence that acquired operations have revenue quality comparable with listed drone peers AVAV and KTOS; absent that, ACHR remains valued as a pre-revenue eVTOL option. Over 6-18 months, a credible defense revenue stream could lower the cost of capital and improve supplier bargaining power, while a delay in FAA progress or another equity raise would compound dilution risk.

The contrarian point is that sub-$6 does not itself establish asymmetry: a lower share price is immaterial if the company must finance years of certification and production losses. Conversely, the market may underappreciate the strategic value of a Boeing relationship if it converts into manufacturing support, defense procurement access, or a future strategic floor under the equity. The thesis is falsified by material share issuance for the acquired assets, revised certification timing, or cash runway falling below roughly 12 months without committed non-dilutive funding.

Key Decisions for Investors

• Do not initiate a core ACHR long before the Boeing transaction filing. Set an event-driven alert for disclosed consideration, liabilities, backlog, and standalone revenue; only consider a starter position after terms demonstrate limited dilution and identifiable defense cash flow.
• For high-risk tactical exposure, use a small defined-risk ACHR call spread dated 6-12 months after the next major FAA certification milestone rather than common equity. Target at least 3:1 payoff to premium; exit if certification guidance slips or a financing is announced before the milestone.
• Prefer a quality defense-autonomy basket long AVAV and KTOS versus ACHR as the funding-risk hedge over the next 3-6 months. The pair benefits if defense drone demand accelerates while the market continues to penalize pre-commercial aviation duration.
• Monitor BA for second-order optionality rather than buy solely on this transaction: a retained equity stake or supply/manufacturing relationship could create upside with limited capital deployment, but any open-ended support obligations or adverse transaction accounting would negate that benefit.